The Phase III STELLAR trial evaluated the eflornithine and lomustine combination in patients with IDH mutant astrocytoma.

Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib ...

The intranasal brain delivery system, which is in phase II clinical trials, is already helping patients whose tumors had previously stopped responding to treatment.

A young woman has been diagnosed with an incurable brain tumour after doctors dismissed her symptoms as panic attacks. Jessie ...

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor ...

2013;10(4):405-412 ... including pilocytic astrocytomas, gangliogliomas, pleomorphic xanthoastrocytomas and high- and low-grade diffusely infiltrating gliomas. The common effect through all ...

Outcomes of patients with isocitrate dehydrogenase-mutant WHO Grade 4 astrocytoma treated with Tumor Treating Fields (TTFields) therapy: a real-world analysis Presenting Author: Jennifer M.

The E3F05 trial started in September 2009 and enrolled patients with low-grade gliomas who had not received prior radiation ...

Advice for first-time home buyers from Money Box Live.

作为全球首款IDH1 ...

Frank Cottrell-Boyce and Cressida Cowell recommend a selection of children’s books.

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor ...